Stryker (SYK) Income from Continuing Operations (2009 - 2026)
Stryker's (SYK) quarterly Income from Continuing Operations came in at 745000000.0 in Q1 2026, up 13.91% year-on-year from 654000000.0 in Q1 2025, and down 12.25% on a QoQ basis from 849000000.0 in Q4 2025.
Stryker (SYK) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Income from Continuing Operations data on file, last reported at 745000000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 13.91% year-over-year to 745000000.0 in Q1 2026; TTM through Mar 2026 was 3337000000.0, a 16.72% increase from a year earlier, with the FY2025 full-year figure at 3246000000.0, up 8.45% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 745000000.0, down from 849000000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for SYK reached as high as 1143000000.0 in Q4 2023 and fell as low as 323000000.0 in Q1 2022.
- Historically, Income from Continuing Operations has averaged 735705882.35 across 5 years, with a median of 745000000.0 in 2026.
- Across the five-year window, Income from Continuing Operations jumped 103.02% in 2023 and slumped 52.23% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 563000000.0 in 2022, then soared by 103.02% to 1143000000.0 in 2023, then slumped by 52.23% to 546000000.0 in 2024, then surged by 55.49% to 849000000.0 in 2025, then slipped by 12.25% to 745000000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 745000000.0 in Q1 2026, 849000000.0 in Q4 2025, and 859000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 220.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 745.00 Mn |
| Dec 31, 2025 | 849.00 Mn |
| Sep 30, 2025 | 859.00 Mn |
| Jun 30, 2025 | 884.00 Mn |
| Mar 31, 2025 | 654.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 834.00 Mn |
| Jun 30, 2024 | 825.00 Mn |
| Mar 31, 2024 | 788.00 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 692.00 Mn |
| Jun 30, 2023 | 738.00 Mn |
| Mar 31, 2023 | 592.00 Mn |
| Dec 31, 2022 | 563.00 Mn |
| Sep 30, 2022 | 816.00 Mn |
| Jun 30, 2022 | 656.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 662.00 Mn |
| Sep 30, 2021 | 438.00 Mn |
| Jun 30, 2021 | 592.00 Mn |